Jupiter Life Line Hospitals Limited — PPTs, 15-05-2026: Investor Presentation

Jupiter Life Line Hospitals delivered strong FY26 results with Total Income rising 15.2% YoY to 1,499.8 Cr and EBITDA up 14.4% YoY to 343.3 Cr. However, Net Profit (PAT) saw a modest 0.2% increase to 194.2 Cr, partly due to initial operating losses and higher depreciation from the newly opened Dombivli hospital. Average Revenue Per Occupied Bed (ARPOB) also improved.

The company is aggressively expanding, aiming to increase bed capacity to 2,900. Key strategies include securing land in high-demand areas like BKC and commissioning new facilities in phases to optimize capital, reinforcing its leadership in Western India.

FY26 was marked by two significant milestones: acquiring land for a new 400-bed hospital in Mumbai's BKC, and successfully operationalizing the 500-bed Dombivli hospital on February 25, 2026, ahead of schedule. Approximately 200 beds at Dombivli are now operational.

Management views FY26 as a landmark year for strategic growth, acknowledging the short-term impact of new hospital ramp-ups. They remain optimistic, noting strong performance from established hospitals in Thane, Pune, and Indore, with Pune South construction on track for future expansion.